Trials / Completed
CompletedNCT01621386
Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
A Study Comparing Measures of Ventilatory Heterogeneity (VH) in Asthma Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Hal C Charles · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will explore the utility of magnetic resonance imaging (MRI) to assess ventilatory defects that occur due to asthma, determine the sensitivity and specificity of MRI in response to drug treatment, and whether MRI can serve as a biomarker of treatment effects due to asthma therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Montelukast | Administered orally as a single daily 10 mg dose for 2 weeks |
| DRUG | Prednisone | Administered orally as a single daily 20 mg dose for 2 weeks |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-09-01
- Completion
- 2016-03-01
- First posted
- 2012-06-18
- Last updated
- 2017-04-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01621386. Inclusion in this directory is not an endorsement.